Prevalence of retinopathy and associated risk factors among high- and low-risk patients with type 2 diabetes mellitus

References

1. 1.↵
   1. Saeedi P,
   2. Petersohn I,
   3. Salpea P,
   4. Malanda B,
   5. Karuranga S,
   6. Unwin N, et al.

   IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 2019; 157: 107843.
2. 2.↵
   International Diabetes Federation. Diabetes Atlas, 9th ed. (Updated 2019. Accessed 2021 January 1). Available from URL: https://www.diabetesatlas.org/en/
3. 3.↵
   1. Cheloni R,
   2. Gandolfi SA,
   3. Signorelli C,
   4. Odone A.

   Global prevalence of diabetic retinopathy: protocol for a systematic review and meta-analysis. BMJ Open 2019; 9: e022188.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Ting DS,
   2. Cheung GC,
   3. Wong TY.

   Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Exp Ophthalmol 2016; 44: 260–277.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Al-Ghamdi AS.

   Adults visual impairment and blindness - An overview of prevalence and causes in Saudi Arabia. Saudi J Ophthalmol 2019; 33: 374–381.

   OpenUrl
6. 6.↵
   1. Magliah SF,
   2. Bardisi W,
   3. Al Attah M,
   4. Khorsheed MM.

   The prevalence and risk factors of diabetic retinopathy in selected primary care centers during the 3-year screening intervals. J Family Med Prim Care 2018; 7: 975–981.

   OpenUrl
7. 7.↵
   1. Yasir ZH,
   2. Hassan AD,
   3. Rajiv K.

   Diabetic retinopathy (DR) among 40 years and older Saudi population with diabetes in Riyadh governorate, Saudi Arabia - A population based survey. Saudi J Ophthalmol 2019; 33: 363–368.

   OpenUrl
8. 8.↵
   1. Ahmed RA,
   2. Khalil SN,
   3. Al-Qahtani MA.

   Diabetic retinopathy and the associated risk factors in diabetes type 2 patients in Abha, Saudi Arabia. J Family Community Med 2016; 23: 18–24.

   OpenUrl
9. 9.↵
   1. Sherwani SI,
   2. Khan HA,
   3. Ekhzaimy A,
   4. Masood A,
   5. Sakharkar MK.

   Significance of HbA1c Test in diagnosis and prognosis of diabetic patients. Biomark Insights 2016; 11: 95–104.

   OpenUrl
10. 10.↵
    1. Duh EJ,
    2. Sun JK,
    3. Stitt AW.

    Diabetic retinopathy: current understanding, mechanisms, and treatment strategies. JCI Insight 2017; 2: e93751.

    OpenUrl
11. 11.↵
    IBM Corp N. IBM SPSS statistics for windows. IBM Corp, Armonk, NY. 2010. [Updated 2021. Accessed 2019]. Available from: https://www.ibm.com/support/pages/how-cite-ibm-spss-statistics-or-earlier-versions-spss
12. 12.↵
    Raosoft. Raosoft Sample Size Calculator. [Updated 2004. Accessed 2020]. Available from: http://www.raosoft.com/samplesize.html
13. 13.↵
    1. Martinell M,
    2. Dorkhan M,
    3. Stålhammar J,
    4. Storm P,
    5. Groop L,
    6. Gustavsson C.

    Prevalence and risk factors for diabetic retinopathy at diagnosis (DRAD) in patients recently diagnosed with type 2 diabetes (T2D) or latent autoimmune diabetes in the adult (LADA). J Diabetes Complications 2016; 30: 1456–1461.

    OpenUrlPubMed
14. 14.↵
    1. Tan GS,
    2. Gan A,
    3. Sabanayagam C,
    4. Tham YC,
    5. Neelam K,
    6. Mitchell P, et al.

    Ethnic differences in the prevalence and risk factors of diabetic retinopathy: the Singapore epidemiology of eye diseases study. Ophthalmology 2018; 125: 529–536.

    OpenUrlPubMed
15. 15.↵
    1. Zhou Y,
    2. Wang C,
    3. Shi K,
    4. Yin X.

    Relationship between dyslipidemia and diabetic retinopathy: A systematic review and meta-analysis. Medicine (Baltimore) 2018; 97: e12283.

    OpenUrl